Stay updated on Fremanezumab, Migraine, Sleep Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab, Migraine, Sleep Clinical Trial page.

Latest updates to the Fremanezumab, Migraine, Sleep Clinical Trial page
- Check5 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded entries noting poor enrollment and that results have been posted, with updates to Outcome Measures (Results), Outcome Measures, and Study Status. A prior narrative about enrollment difficulties and termination was deleted.SummaryDifference0.8%

- Check20 days agoChange DetectedReturned: 2026-02-24 with updates to core study content including Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Arms/Interventions, and Study Status, and a note that Quality Control Review Has Not Concluded.SummaryDifference1%

- Check34 days agoChange DetectedAdded history entries for 'Results Submitted' and 'Revision: v3.4.2'. Removed older items including 'No Results Posted', 'Revision: v3.4.1', and the government funding notice.SummaryDifference0.9%

- Check41 days agoChange DetectedA site-wide funding-status notice was added and the revision label updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check48 days agoChange DetectedStudy status changed from Recruiting to Terminated with an explanation that recruitment targets were not met. The update also adds a Show glossary option and notes the 2026-01-23 revision.SummaryDifference2%

Stay in the know with updates to Fremanezumab, Migraine, Sleep Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab, Migraine, Sleep Clinical Trial page.